MetLife Investment Management’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,582
| Closed | -$88.3K | – | 2812 |
|
|
2024
Q3 | $88.3K | Buy |
12,582
+7,089
| +129% | +$49.8K | ﹤0.01% | 2672 |
|
|
2024
Q2 | $37.7K | Buy |
+5,493
| New | +$37.7K | ﹤0.01% | 2808 |
|
|
2021
Q2 | – | Sell |
-2,389
| Closed | -$236K | – | 2438 |
|
|
2021
Q1 | $236K | Sell |
2,389
-1,373
| -36% | -$135K | ﹤0.01% | 1966 |
|
|
2020
Q4 | $408K | Hold |
3,762
| – | – | ﹤0.01% | 1587 |
|
|
2020
Q3 | $387K | Buy |
3,762
+501
| +15% | +$51.6K | ﹤0.01% | 1504 |
|
|
2020
Q2 | $681K | Buy |
3,261
+405
| +14% | +$84.6K | 0.01% | 1211 |
|
|
2020
Q1 | $279K | Hold |
2,856
| – | – | ﹤0.01% | 1512 |
|
|
2019
Q4 | $329K | Hold |
2,856
| – | – | ﹤0.01% | 1686 |
|
|
2019
Q3 | $156K | Hold |
2,856
| – | – | ﹤0.01% | 2081 |
|
|
2019
Q2 | $340K | Hold |
2,856
| – | – | ﹤0.01% | 1718 |
|
|
2019
Q1 | $150K | Buy |
+2,856
| New | +$150K | ﹤0.01% | 2145 |
|
|
2018
Q4 | – | Sell |
-2,834
| Closed | -$171K | – | 2569 |
|
|
2018
Q3 | $171K | Hold |
2,834
| – | – | ﹤0.01% | 2175 |
|
|
2018
Q2 | $150K | Buy |
+2,834
| New | +$150K | ﹤0.01% | 2052 |
|